Development of fragment-specific osteopontin antibodies and ELISA for quantification in human metastatic breast cancer
<p>Abstract</p> <p>Background</p> <p>Osteopontin (OPN) is associated with human cancers, and circulating blood OPN may have diagnostic or prognostic value in clinical oncology.</p> <p>Methods</p> <p>To evaluate OPN as a cancer biomarker, we gener...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2008-01-01
|
| Series: | BMC Cancer |
| Online Access: | http://www.biomedcentral.com/1471-2407/8/38 |